EL7.AI
StocksMedium•10 November 2026•
3 min read

Octave Reaffirms $80 Million Adjusted Consolidated Earnings Target by 2028

Key Facts

1Octave reaffirmed its target of $80 million in adjusted consolidated EBITDA attributable to shareholders by 2028.
2Distribution segment revenue was $58.364 million in the third quarter of 2026, up 35.0%, with organic growth of 22.6%.
3Adjusted EBITDA attributable to shareholders in the distribution segment rose to $8.3 million from $6 million a year earlier.
4Group revenue grew 28% to $85.3 million in the third quarter of 2026, from $66.6 million a year earlier.

Octave Specialty Group said it remains confident in achieving its target of $80 million in adjusted consolidated EBITDA attributable to shareholders by 2028. The announcement came during the company’s third-quarter earnings call on November 10, 2026. Management said its confidence is based on growth in both of the company’s segments and corporate cost savings it expects from integration and technology solutions. It also said it expects to exceed its 2026 guidance for adjusted EBITDA attributable to shareholders in the distribution segment, without formally raising the guidance. These expectations put growth in the distribution business on the company’s path toward its consolidated financial target.

The distribution segment recorded revenue of $58.364 million in the third quarter of 2026, up 35.0% from the year-earlier period. Organic revenue growth was 22.6%, according to the company’s reconciliation in its filing with the U.S. Securities and Exchange Commission. Adjusted EBITDA attributable to shareholders in the segment rose to $8.3 million, compared with $6 million a year earlier. The adjusted EBITDA margin increased to 14.2% from 13.9% in the third quarter of 2025. Revenue growth came alongside improved profitability and margins, while management said the segment was on track to exceed its annual organic growth guidance of 25%+.

At the group level, total revenue in the third quarter of 2026 rose 28% to $85.3 million, from $66.6 million in the year-earlier quarter. The company attributed the increase to organic revenue growth and the acquisition of ArmadaCare, as well as a 52% rise in Everspan earned premiums. Management said the acquisition of ArmadaCare was completed in October 2025, and that MGAs launched in 2024 and 2025, along with the ESL and A&E lines, also contributed to revenue growth. Adjusted consolidated EBITDA attributable to shareholders turned to a profit of $3.3 million in the third quarter, from a loss of $2.9 million a year earlier. The loss from continuing operations attributable to shareholders narrowed to $13.8 million from $31.7 million in the year-earlier period.

Management said it expects double-digit organic growth in the distribution segment in the fourth quarter of 2026 and is on track to exceed its annual organic growth guidance of 25%+. The chief executive added that the segment’s capacity for 2027 is “largely in place,” and that its AI-based underwriting platform supports its U.S. MGAs. He said the company sees the distribution segment as positioned to continue outpacing the industry, with operating capacity available and the platform providing support. In its earnings release, the company forecast that the insurance market would continue to soften through 2027 and said its operating model was designed to work across market cycles. The company made a replay of the earnings call available through November 24, 2026.